BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours

MLA

Zeynep Eroglu, et al. “BESPOKE IO Protocol: A Multicentre, Prospective Observational Study Evaluating the Utility of CtDNA in Guiding Immunotherapy in Patients with Advanced Solid Tumours.” BMJ Open, vol. 12, no. 5, May 2022. EBSCOhost, https://doi.org/10.1136/bmjopen-2021-060342.

APA

Zeynep Eroglu, Joe Ensor, Meenakshi Malhotra, Paul Billings, Angel Rodriguez, Alexey Aleshin, Ling Gao, Sarah Sawyer, Pashtoon Murtaza Kasi, Sascha Ellers, George Ansstas, Michael Krainock, Sakti Chakrabarti, Andrew Poklepovic, & Minu Maninder. (2022). BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours. BMJ Open, 12(5). https://doi.org/10.1136/bmjopen-2021-060342

Chicago

Zeynep Eroglu, Joe Ensor, Meenakshi Malhotra, Paul Billings, Angel Rodriguez, Alexey Aleshin, Ling Gao, et al. 2022. “BESPOKE IO Protocol: A Multicentre, Prospective Observational Study Evaluating the Utility of CtDNA in Guiding Immunotherapy in Patients with Advanced Solid Tumours.” BMJ Open 12 (5). doi:10.1136/bmjopen-2021-060342.